Moleculin Biotech, Inc.

MBRX Stock Healthcare Biotechnology
$0.28
-0.09 (-24.24%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-64.1%
3 Months
-86.9%
YTD
-91.5%
1 Year
-97.8%
3 Year annualized
-88.5%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
132.0%
Largest decline max drawdown, since Oct 2021
-100.0%
Risk-adjusted return Sharpe ratio, 1-year
-2.03

Own MBRX?

See how MBRX contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.